EyePoint Pharmaceuticals (EYPT) Change in Cash: 2010-2019
Historic Change in Cash for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to -$27.6 million.
- EyePoint Pharmaceuticals' Change in Cash rose 24.04% to -$27.6 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$48.9 million, marking a year-over-year decrease of 591.68%. This contributed to the annual value of -$181.6 million for FY2024, which is 197.81% down from last year.
- Latest data reveals that EyePoint Pharmaceuticals reported Change in Cash of -$27.6 million as of Q4 2019, which was down 1,369.18% from -$1.9 million recorded in Q1 2019.
- EyePoint Pharmaceuticals' Change in Cash's 5-year high stood at $25.9 million during Q2 2018, with a 5-year trough of -$36.4 million in Q4 2018.
- For the 3-year period, EyePoint Pharmaceuticals' Change in Cash averaged around -$1.8 million, with its median value being $1.1 million (2017).
- Within the past 5 years, the most significant YoY rise in EyePoint Pharmaceuticals' Change in Cash was 543.16% (2018), while the steepest drop was 3,590.22% (2018).
- Over the past 5 years, EyePoint Pharmaceuticals' Change in Cash (Quarterly) stood at -$2.9 million in 2015, then climbed by 8.86% to -$2.6 million in 2016, then spiked by 139.76% to $1.0 million in 2017, then tumbled by 3,590.22% to -$36.4 million in 2018, then increased by 24.04% to -$27.6 million in 2019.
- Its Change in Cash was -$27.6 million in Q4 2019, compared to -$1.9 million in Q1 2019 and -$36.4 million in Q4 2018.